Predicting treatment outcomes using (18)F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy

BACKGROUND: Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemoimmunotherapy. We aimed to evaluate whether imaging biomarkers of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chang Gon, Hwang, Sang Hyun, Kim, Kyung Hwan, Yoon, Hong In, Shim, Hyo Sup, Lee, Ji Hyun, Han, Yejeong, Ahn, Beung-Chul, Hong, Min Hee, Kim, Hye Ryun, Cho, Byoung Chul, Cho, Arthur, Lim, Sun Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753071/
https://www.ncbi.nlm.nih.gov/pubmed/35035536
http://dx.doi.org/10.1177/17588359211068732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753071/
https://www.ncbi.nlm.nih.gov/pubmed/35035536
http://dx.doi.org/10.1177/17588359211068732

Ejemplares similares